Correction to: Prospective observational study on Pazopanib in patients treated for advanced or metastatic renal cell carcinoma in countries in Asia Pacific, North Africa, and Midd...

por Mustafa Erman, Bivas Biswas, Pongwut Danchaivijitr, Lingwu Chen, Yoke Fui Wong, Tarek Hashem, Chun Sen Lim, Bulent Karabulut, Hsiao-Jen Chung, Chandrasekhar Chikatapu, Sara Ingles, Khemaies Slimane, Ravindran Kanesvaran
Publicado 2021

Matched cohort study of germline BRCA mutation carriers with triple negative breast cancer in brightness

por Otto Metzger-Filho, Katharine Collier, Sarah Asad, Peter J. Ansell, Mark Watson, Junu Bae, Mathew Cherian, Joyce O’Shaughnessy, Michael Untch, Hope S. Rugo, Jens B. Huober, Mehra Golshan, William M. Sikov, Gunter von Minckwitz, Priya Rastogi, Lang Li, Lijun Cheng, David Maag, Norman Wolmark, Carsten Denkert, W. Fraser Symmans, Charles E. Geyer, Sibylle Loibl, Daniel G. Stover
Publicado 2021

Correction to: Co-relation with novel phosphorylation sites of IκBα and necroptosis in breast cancer cells

por Sung Hoon Choi, Hee-Sub Yoon, Shin-Ae Yoo, Sung Ho Yun, Joo-Hee Park, Eun Hee Han, Sung-Gil Chi, Young-Ho Chung
Publicado 2021

ROR1 and ROR2 expression in pancreatic cancer

por Dongli Liu, George Sharbeen, Phoebe Phillips, Australian Pancreatic Cancer Genome Initiative, Caroline E. Ford
Publicado 2021

A Novel Pyroptosis-Related lncRNAs Signature for Predicting the Prognosis of Kidney Renal Clear Cell Carcinoma and Its Associations with Immunity

por Xinfang Tang, Anna Zhang, Yuanyuan Feng, Ying Su, Xiaoyu Wang, Feng Jiang, Jianxin Ma
Publicado 2021

Use of Intraoperative Frozen Section in the Surgical Management of Patients with Nonmelanoma Skin Cancer

por LiAnn Loh, Priya Tiwari, Jingtzer Lee, O-Wern Low, Vigneswaran Nallathamby, Hanjing Lee, Jane Lim, Thiam Chye Lim, Yan Lin Yap
Publicado 2021

Na+/H+-Exchanger Family as Novel Prognostic Biomarkers in Colorectal Cancer

por Xin Zhou, Manman Jiang, Zhihong Liu, Mengmeng Xu, Nannan Chen, Ziyu Wu, Changji Gu, Eugene Chin, Xiaodong Yang
Publicado 2021

Establishment and Characterization of a Novel Dedifferentiated Chondrosarcoma Cell Line DDCS2

por Xiaoyang Li, Dylan C. Dean, Al Ferreira, Scott D. Nelson, Francis J. Hornicek, Shengji Yu, Zhenfeng Duan
Publicado 2021

Simple and effective bacterial-based intratumoral cancer immunotherapy

por Teresa Neeman, Desmond Yip, Rachel Allavena, Jane E Dahlstrom, Christina S E Carroll, Erin R Andrew, Laeeq Malik, Kathryn F Elliott, Moira Brennan, James Meyer, Alexander Hintze, Andrew A Almonte, Cassandra Lappin, Philip MacPherson, Klaus-Martin Schulte, Rohit Tamhane, Elizabeth W Herbert, Maurice Orange, Aude M Fahrer
Publicado 2021

Pembrolizumab with low-dose carboplatin for recurrent platinum-resistant ovarian, fallopian tube, and primary peritoneal cancer: survival and immune correlates

por Mary L Disis, John B Liao, Doreen M Higgins, Jennifer S Childs, Sasha E Stanton, Anna V Tinker, William R Gwin, Renata R Urban, Katie M Hitchcock-Bernhardt, Andrew L Coveler, Hania N Shakalia, Ron E Swensen, Tanya A Wahl, Richard G Ancheta, Kathryn F McGonigle, James Y Dai, Barbara A Goff
Publicado 2021

Effect of a multidisciplinary Severe Immunotherapy Complications Service on outcomes for patients receiving immune checkpoint inhibitor therapy for cancer

por Michael Dougan, Justine Cohen, Dejan Juric, Leyre Zubiri, Ryan J Sullivan, Daniel A Zlotoff, Yevgeniy R Semenov, Sara R Schoenfeld, Genevieve M Boland, Amanda C Guidon, Laura Petrillo, Alexandra-Chloe Villani, Gabriel E Molina, Sienna M Durbin, Molly F Thomas, Alex T Faje, Michelle Rengarajan, Daniel Okin, Benjamin D Medoff, Mazen Nasrallah, Minna J Kohler, Jocelyn R Farmer, Aditya Bardia, Steven M Blum, Rebecca K Leaf
Publicado 2021

Systematic preclinical evaluation of CD33-directed chimeric antigen receptor T cell immunotherapy for acute myeloid leukemia defines optimized construct design

por Haiying Qin, Nirali N Shah, Terry J Fry, Lila Yang, John A Chukinas, Samiksha Tarun, Marie Pouzolles, Christopher D Chien, Lisa M Niswander, Anthony R Welch, Sarah K Tasian, Naomi A Taylor
Publicado 2021

Clinicopathological and Prognostic Significance of PRMT5 in Cancers: A System Review and Meta-Analysis

por Zhenzhen Liang PhD, Lianchang Liu PhD, Chaowei Wen PhD, Heya Jiang MSci, Tianxia Ye MSci, Shumei Ma PhD, Xiaodong Liu PhD
Publicado 2021

Prostate Cancer in Lebanon: Incidence, Temporal Trends, and Comparison to Countries From Different Regions in the World

por Najla A. Lakkis, Mona H. Osman
Publicado 2021

Durable Response with Single-Agent Pembrolizumab in a Patient with Metastatic Melanoma

por Sanju Cyriac, Ajith Toms, Sunitha Thomas
Publicado 2021

Gemcitabine plus Nab-paclitaxel as a second-line treatment following FOLFIRINOX failure in advanced pancreatic cancer: a multicenter, single-arm, open-label, phase 2 trial

por Gunn Huh, Hee Seung Lee, Jin Ho Choi, Sang Hyub Lee, Woo Hyun Paik, Ji Kon Ryu, Yong-Tae Kim, Seungmin Bang, Eaum Seok Lee
Publicado 2021

Morphology and Immunoprofiling of Benign Lymphoid Aggregates in Bone Marrow Biopsies of Lymphoma Patients

por Supreet Kaur Kalra, Sankalp Sancheti, Puneet Kaur Somal, Akash Pramod Sali, Alok Goel, Shivani Jain, Rakesh Kapoor
Publicado 2021

In Vitro Evaluation of Anticancer Activity (Efficacy) of a Novel Ayurvedic Polyherbal Formulation on Human Oral Carcinoma Cell Line SCC-40

por Sandeep Charak, Monika Sharma, Sharad M. Porte
Publicado 2021

Application of Lipidomics for Assessing Tissue Lipid Profiles of Patients With Squamous Cell Carcinoma

por Weibiao Zeng MD, Wen Zheng MD, Sheng Hu MD, Jianyong Zhang MD, Wenxiong Zhang MD, Jianjun Xu MD, Dongliang Yu MD, Jinhua Peng MD, Lu Zhang MD, Meng Gong MD, Yiping Wei MD
Publicado 2021

A triple negative breast cancer: what it is not!

por Katakkar SB
Publicado 2012